deltatrials
Terminated PHASE1 INTERVENTIONAL 1-arm NCT03121677

Personalized Tumor Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma

Pilot Study of a Personalized Tumor Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma

Sponsor: Washington University School of Medicine

Conditions Follicular Lymphoma
Interventions Biopsy Leukapheresis Nivolumab Peripheral blood draws Personalized tumor vaccine Poly ICLC Rituximab
Updated 19 times since 2017 Last updated: Aug 9, 2023 Started: Oct 16, 2018 Primary completion: Sep 24, 2020 Completion: Aug 7, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Vaccine manufacturing has been suspended

Other terminated trials from Washington University School of Medicine

See all terminations from Washington University School of Medicine

Other Follicular Lymphoma trials with similar outcome

Browse all Follicular Lymphoma trials

This PHASE1 trial investigates Follicular Lymphoma and is currently terminated or withdrawn. Washington University School of Medicine leads this study, which shows 19 recorded versions since 2018 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Nov 2018 · 3 months · monthly snapshot~Nov 2018 – ~Dec 2018 · 30 days · monthly snapshot~Dec 2018 – ~May 2019 · 5 months · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Dec 2019 · 6 months · monthly snapshot~Dec 2019 – ~Apr 2020 · 4 months · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Dec 2020 · 7 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Oct 2022 · 10 months · monthly snapshot~Oct 2022 – ~Sep 2023 · 11 months · monthly snapshot~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 12 months · monthly snapshot

Change History

19 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE1

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1

  4. Sep 2023 — Jul 2024 [monthly]

    Terminated PHASE1

    Status: Active Not Recruiting → Terminated

  5. Oct 2022 — Sep 2023 [monthly]

    Active Not Recruiting PHASE1

    Status: Suspended → Active Not Recruiting

▶ Show 14 earlier versions

  1. Dec 2021 — Oct 2022 [monthly]

    Suspended PHASE1

    Status: Recruiting → Suspended

  2. Jan 2021 — Dec 2021 [monthly]

    Recruiting PHASE1

  3. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE1

  4. May 2020 — Dec 2020 [monthly]

    Recruiting PHASE1

  5. Apr 2020 — May 2020 [monthly]

    Recruiting PHASE1

  6. Dec 2019 — Apr 2020 [monthly]

    Recruiting PHASE1

  7. Jun 2019 — Dec 2019 [monthly]

    Recruiting PHASE1

  8. May 2019 — Jun 2019 [monthly]

    Recruiting PHASE1

  9. Dec 2018 — May 2019 [monthly]

    Recruiting PHASE1

  10. Nov 2018 — Dec 2018 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  11. Aug 2018 — Nov 2018 [monthly]

    Not Yet Recruiting PHASE1

  12. Jul 2018 — Aug 2018 [monthly]

    Not Yet Recruiting PHASE1

  13. Jun 2018 — Jul 2018 [monthly]

    Not Yet Recruiting PHASE1

  14. Jun 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Washington University School of Medicine
Data source: Washington University School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations